What is the role of the pharmacist in patient-centered care of adults with type 2 diabetes (T2D)? Join pharmacist experts in T2D Jennifer Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, Melody Hartzler, PharmD, BCACP, BC-ADM, AE-C, and Donald Nuzum, PharmD, BCACP, BC-ADM, CDCES, as they discuss education of patients and pharmacists on the pharmacokinetics, administration, dosing schedule and handling of a GLP-1 receptor agonist (GLP-1 RA). They will also consider when to use a GLP-1 RA, where they review clinical data on efficacy and safety of a GLP-1 RA, including in a trial when used as monotherapy vs placebo, a head-to-head study vs a DPP-4 inhibitor, and a cardiovascular outcomes study.

This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

Faculty Presenters:

Jennifer D. Goldman, PharmD, CDCES, BC-ADM, FCCP
Professor of Pharmacy Practice & Clinical Pharmacist, Director of Cardiometabolic Services
Massachusetts College of Pharmacy and Health Sciences, Boston, MA; Well Life Medical, Peabody, MA

Melody L. Hartzler, PharmD, BCACP, BC-ADM
Clinical Pharmacist & CEO
PharmToTable, LLC
Centerville, OH

Donnie Nuzum, PharmD, BCACP, BC-ADM, CDCES
Associate Professor of Pharmacy, Clinical Pharmacist
Wingate University, Avance Primary Care
Indian Trail, North CA